Bio-Techne (TECH) Reports In-Line Q4 EPS, misses on revenue
Tweet
Share
E-mailGet Alerts TECH Hot Sheet
Price: $55.61 -4.02%
Revenue Growth %: +1.1%
Financial Fact:
Selling, general and administrative: 46.26M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +1.1%
Financial Fact:
Selling, general and administrative: 46.26M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $0.55, in-line with the analyst estimate of $0.55. Revenue for the quarter came in at $301.32 million versus the consensus estimate of $307.61 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
